IL6 and malaria: Our final limitation remains the challenge of interpreting germline variation relating to a lifetime exposure to changes in IL-6 signaling as evidence for or against the therapeutic usage of IL-6 antagonism in acute malaria or for elucidating the causal role of IL-6 in severe malaria.